On Monday, November 18th, six extraordinary members of our Crothall Environmental Services team proudly represented us as the “Cleaning Crusaders” at the 2024 IEHA Housekeeping Olympics in Las Vegas, Nevada. This prestigious event transforms cleaning into an Olympic sport, drawing top teams from around the globe. While traditionally aimed at the hospitality industry, the competition…
Peter Yellowlees MD is CEO at Asynch Health–this is a new company that is doing the intake interview for a psychiatrist or psychologist session. Peter demos how the AI agent asks questions, how a patient answers in real time. Then after submitting the answers, the AI creates both a full transcript in the back end,…
As healthcare systems actively recalibrate their diagnostic strategies, evolved nasal lavage presents a safer, smarter specimen collection standard that results in more accurate and timely diagnosis plus more effective virus containment. The post Is Evolved Nasal Lavage a Solution for Post-Pandemic URI Test Avoidance? appeared first on MedCity News.
This analysis examines the share of inpatient hospital days that are covered by Medicaid nationally and by state at a time when Congress is considering potential cuts to the program. It finds that Medicaid covered at least one in five inpatient hospital days in 48 states and the District of Columbia in 2023.
Ouro Medicines’ drugs deplete disease-driving immune cells, allowing the immune system to reset with naïve cells that don’t attack the body. Monograph Capital founded the startup in partnership with GSK. The post Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System appeared first on MedCity News.
Improving the identification and validation of disease-specific drug targets in a cell-type and patient-specific manner early on will not only reduce the failure rate and cost that is so inherent in current drug development processes but also allow the development of more effective precision medicines, improving patient outcomes. The post The Future of Drug Discovery…
The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups that the move will sharply raise premiums and reduce affordable coverage. The post Health Experts Warn of ‘Devastating’ Impact After Senate Rejects ACA Tax Credit Extension appeared first on MedCity News.
Randy Bolyga, founder CEO of RXNT, built his medical software company without venture capital, relying instead on SBA loans and a conservative, cash-positive growth strategy. He believes many venture capital-backed healthcare startups fail because they chase rapid growth without sustainable business models or a deep understanding of the market. The post Why One Healthcare Founder…
Expert notes that insurance coverage remains poor for obesity as a medical condition
The six new drugs awarded FDA Commissioner’s National Priority Vouchers brings to 15 the total number of therapies selected for the new pilot program. Under this program, the FDA says the standard 10- to 12-month review time could be shaved down to “within months.” The post FDA Adds 6 More Meds to Pilot Program for…